Results 161 to 170 of about 655,167 (267)

Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge

Klebsiella pneumoniae is a major agent of healthcare-associated infections and a cause of some community-acquired infections, including severe bacteremic infections associated with metastatic abscesses in liver and other organs.
Simona Pollini (304648), Marco Maria D’Andrea (8477952), Vivi Miriagou (17872074), Vincenzo Di Pilato (5807162), Gian Maria Rossolini (141530)   +4 more
core   +1 more source

Cefdinir binding to a class A β‐lactamase revealed by serial cryo‐crystallography

Acta Crystallographica Section D, Volume 82, Issue 6, Page 672-682, June 2026.
Serial cryo‐crystallography reveals the structure of the extended‐spectrum β‐lactamase CTX‐M‐14 in complex with the third‐generation cephalosporin antibiotic cefdinir.One of the most common resistance mechanisms against antibiotics employed by Gram‐negative bacteria involves the production of β‐lactamases, resulting in rapid hydrolysis of the ...
Gargi Gore, Andreas Prester, Kim Bartels, David von Stetten, Eike C. Schulz   +4 more
wiley   +1 more source

Isolation of a Novel Lytic Pseudomonas aeruginosa Phage Henu5 and Fitness Costs of Phage‐Driven Resistance

Microbial Biotechnology, Volume 19, Issue 6, June 2026.
This study isolated and identified a novel lytic phage that infects Pseudomonas aeruginosa. Henu5 exhibited good physicochemical stability. Additionally, the phage‐resistant mutants showed fitness trade‐offs in growth, virulence and antibiotic susceptibility, along with in vivo fitness, which might direct future phage selection in clinical settings ...
Salwa E. Gomaa, Jiawen Shen, Jingjing Li, Yangyang Liu, Chaonan Ma, Qiming Li, Guanbin Qi, Tieshan Teng   +7 more
wiley   +1 more source

Clinical and Microbiological Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Associated Recurrent Urinary Tract Infections

Huijun Cao,1,2,* Hang Cheng,3,* Jing Zhou,3 Jiyuan Zhao,3 Mei Xu,1 Ying Fei1 1Center for Clinical Laboratories, the Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China; 2College of Life Sciences, Fujian Normal ...
Xu M, Cao H, Fei Y, Cheng H, Zhao J, Zhou J   +5 more
core  

Antimicrobial Secondary Metabolites From Rhizosphere‐Associated Streptomyces Species in Northern Nigerian Agricultural Soils: Genomic Mining and Bioactivity Assessment

Environmental Microbiology Reports, Volume 18, Issue 3, June 2026.
Nigerian agricultural soils harbour diverse Streptomyces species producing novel antimicrobial secondary metabolites. Genomic mining revealed 187 biosynthetic gene clusters, leading to isolation of twelve new compounds with potent activity against multidrug‐resistant pathogens, including MRSA and vancomycin‐resistant Enterococcus. ABSTRACT Streptomyces
David Adeiza Zakari, Sarafadeen Olateju Kareem, Obuotor Tolulope Mobolaji, Akinloye Oluseyi Adeboye, Adefila Moyosore Adebimpe   +4 more
wiley   +1 more source

Contemporary multicentre analysis of carbapenemases distribution among clinical carbapenem-resistant Enterobacterales in Lebanon. [PDF]

JAC Antimicrob Resist
Tannous J, Saliba R, Mghames A, Tokajian S, Attieh R, Jisr T, Barhoun J, Diab MK, Shakra DA, Mokhbat J, Al Souheil A, Zorkot W, Jaffal F, Salman H, Husni R, Rahban H, Khoury E, Mohsen Z, Abboud E, Youssef M, Karayakoupoglo G, Fawaz I, Houmani M, Abdallah D, Moghnieh R.   +24 more
europepmc   +1 more source

Modulation of Quorum Sensing and Virulence Gene Expression in Escherichia coli by Extracts of Physalis alkekengi

Environmental Microbiology Reports, Volume 18, Issue 3, June 2026.
Root extracts of Physalis alkekengi were examined for activity against multidrug‐resistant (MDR) Escherichia coli. The ethanolic extract suppressed bacterial growth, lowered biofilm formation by ~63%, and markedly reduced expression of luxS and fimH. Findings highlight P.
Mansoureh Esfandiyari Doolaby, Mohammad Javad Mehdipour Moghaddam, Akbar Norastehnia   +2 more
wiley   +1 more source

Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]

Front Pharmacol
Xu W, Shang L, Li X, Yu J, Shen J, Li Y, He Q, Chen L, Wang D, Wei Y, Niu S.   +10 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Sulbactam-Durlobactam for Carbapenem-Resistant <i>Acinetobacter baumannii-calcoaceticus</i> Complex. [PDF]

Pathogens
Nappi F.
europepmc   +1 more source